Alicia Morgans, MD, MPH, FASCO

Alicia Morgans, MD, MPH of Dana-Farber Cancer Institute

Alicia Morgans, MD, MPH, is a Genitourinary Medical Oncologist and the Director of the Survivorship Program at Dana-Farber Cancer Institute.

Articles by Alicia Morgans, MD, MPH, FASCO

Experts on prostate cancer

Overview of Improvements in Prostate Cancer Management

ByAlicia Morgans, MD, MPH, FASCO,Matthew Smith, MD, PhD,Sandy Srinivas, MBBS, Stanford Cancer Center,Scott T. Tagawa, MD, MS, FACP, Weill Cornell Medicine,Evan Y. Yu, MD, Fred Hutchinson Cancer Research Center

March 30th 2022

Broad discussion on the evolution of care in prostate cancer from both the therapeutic and imaging standpoints.

Trending on OncLive

FDA Approves Iberdomide Plus Daratumumab/Dexamethasone for R/R Myeloma

Dive into the Data Supporting the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma

Five Under 5: Top Oncology Videos for the Week of 8/9

Zipalertinib Plus Chemotherapy Improves PFS in First-Line EGFR Exon 20 Insertion+ NSCLC

FDA Grants Fast Track Designation to Spevatamig in Advanced and Metastatic Biliary Tract Carcinoma